Japanese Healthcare Services Stock News

On December 9, 2025, AGC Inc. held a board meeting to approve changes to its Board of Directors, Audit & Supervisory Board, and Executive Officers, while AGC Biologics earlier partnered with ATUM to integrate the Leap-In Transposase expression platform into its global Cell Line Development Center of Excellence. This collaboration adds a modern transposase-based system alongside AGC Biologics’ CHEF1 Expression Technology, aiming to shorten drug developers’ timelines and broaden the company’s...

If you are wondering whether Mitsubishi Electric is still good value after such a strong run, you are not alone. This article is going to unpack what the current price might really be telling us. The stock has climbed 6.9% over the last week, 7.6% over the past month, and an eye catching 72.7% year to date, building on gains of 78.3% over 1 year and 257.4% over 3 years. Investors have been reacting to Mitsubishi Electric's ongoing strategic push into factory automation and energy efficient...

Artner (TSE:2163) has laid out a mixed Q3 2026 scorecard, with revenue of ¥3.0 billion and net income of ¥252.5 million translating into EPS of ¥23.8, while trailing 12 month revenue came in at ¥11.8 billion with net income of ¥1.3 billion and EPS of ¥125.4. The company has seen quarterly revenue hover around the ¥2.8 billion to ¥3.0 billion range over the past year, with net income moving from ¥279.5 million in Q3 2025 to ¥252.5 million in the latest quarter. This sets up an earnings picture...

As global markets navigate the anticipation of interest rate decisions and mixed economic signals, investors are eyeing potential opportunities in dividend stocks to enhance portfolio stability amid these dynamic conditions. In this environment, a good dividend stock is characterized by consistent payouts and financial resilience, offering a reliable income stream even as market uncertainties persist.

In recent days, Tokyo-listed Metaplanet outlined plans to launch novel perpetual preferred share structures, including its MARS instrument, to raise capital dedicated to expanding its Bitcoin holdings, with a related Mercury digital credit instrument targeted for Japan’s perpetual preferred market by early 2026. By securing a 12‑month head start in Japan after Strategy ruled out issuing similar preferred equity locally, Metaplanet is positioning these new instruments as a potentially...

Recently published market research indicates that the Terahertz Technology market is expected to grow from US$818.7 million in 2025 to about US$1.70 billion by 2030, driven mainly by medical, healthcare, military, and homeland security applications. With Advantest highlighted as a dominant player in this fast-expanding niche, the company’s exposure to terahertz imaging and spectroscopy could become a more meaningful contributor to its broader test and measurement portfolio. We’ll now examine...

Nankai Electric Railway (TSE:9044) just stepped up its ongoing share repurchase, buying 136,600 shares as part of a broader 6 million share plan. This move may be interpreted as a clear signal about management’s confidence in the business. See our latest analysis for Nankai Electric Railway. The buyback comes after a strong run, with Nankai Electric Railway’s year to date share price return of roughly 15% and a one year total shareholder return of about 17%, suggesting momentum is still...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Subaru (TSE:7270) has quietly outperformed much of the auto sector this year, and recent trading suggests investors are reassessing what they are willing to pay for its steady earnings and improving margins. See our latest analysis for Subaru. That strength is not just a one week story. Subaru’s 22.44% year to date share price return and 41.36% one year total shareholder return point to momentum building as investors grow more comfortable with its earnings trajectory and valuation. If...

Mitsui (TSE:8031) has quietly pushed higher, with the share price up about 7% over the past month and nearly 19% in the past 3 months, rewarding patient long term holders. See our latest analysis for Mitsui. Those recent gains sit on top of a much stronger backdrop, with a year to date share price return above 30% and a three year total shareholder return over 130% signaling solid, building momentum rather than a short lived bounce. If Mitsui’s run has you thinking more broadly about Japanese...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...

Nagase & Co., Ltd. recently completed the repurchase of 1,361,600 of its own shares through the Tokyo Stock Exchange’s ToSTNeT-3 system, as part of its broader capital management efforts. This buyback forms a core element of Nagase’s Medium-Term Management Plan ACE 2.0, which targets returning 100% of profits to shareholders over two years and signals a clear shift in its shareholder returns policy. We’ll now examine how this profit-return commitment and share repurchase program shapes...

Pilot (TSE:7846) just wrapped up its latest share buyback, retiring over 1.3 million shares under the program that closed on November 28, 2025. This move tightens the share base for remaining investors. See our latest analysis for Pilot. That buyback has come on the heels of a steady grind higher, with a year to date share price return of 3.59% and a five year total shareholder return of 78.34%. This suggests that long term momentum remains intact even as short term trading stays relatively...

Kura Oncology and Kyowa Kirin recently reported new Phase 1a/1b data showing that KOMZIFTI (ziftomenib), combined with venetoclax and azacitidine, produced encouraging antileukemic activity and a favorable safety profile in patients with acute myeloid leukemia harboring NPM1 mutations or KMT2A rearrangements, with results presented at the 67th ASH Annual Meeting. An important insight is that these findings support ongoing registrational trials that aim to position KOMZIFTI as a core menin...

As global markets navigate a complex landscape of economic indicators, Asian stocks have shown resilience, particularly in sectors like technology and artificial intelligence. In this environment, growth companies with high insider ownership can signal strong internal confidence and potential alignment with shareholder interests.

As global markets closely watch the final Federal Reserve meeting of the year and navigate mixed economic signals, Asian markets have been marked by enthusiasm for technology and AI trades, despite some signs of economic slowdown. In this environment, dividend stocks in Asia offer a compelling option for investors seeking stable income streams amidst market fluctuations.

If you are wondering whether Honda Motor is still a value play after such a long run for auto stocks, or if the easy money has already been made, you are not alone. The stock is up 21.4% over the last year and 56.5% over three years, even though it has slipped 3.8% over the past month and is down 3.4% year to date. Recently, Honda has been in the spotlight for ramping up its electric and hybrid vehicle strategy, including new model rollouts and expanded partnerships in battery technology. At...

Mitsubishi UFJ Financial Group (TSE:8306) recently held a board meeting on November 14 to discuss a potential common stock repurchase, putting shareholder returns and management confidence back in the spotlight for investors. See our latest analysis for Mitsubishi UFJ Financial Group. The repurchase discussion comes after a strong run, with the stock delivering a 33.84% year to date share price return and a 42.24% one year total shareholder return, suggesting recent momentum has been...

Key Insights Gakujo's significant individual investors ownership suggests that the key decisions are influenced by...

We feel now is a pretty good time to analyse Money Forward, Inc.'s ( TSE:3994 ) business as it appears the company may...

Key Insights Institutions' substantial holdings in SG HoldingsLtd implies that they have significant influence over the...

With its stock down 17% over the past three months, it is easy to disregard Ajinomoto (TSE:2802). However, stock prices...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Sansei Technologies' (TSE:6357) stock is up by a considerable 18% over the past three months. We wonder if and what...